Investor Relations
Press releases 2022
Regulatory press release
Fredrik Mella is appointed Senior Vice President of ADDvise Group
Regulatory press release
ADDvise receives order worth USD 1.5 million
Regulatory press release
ADDvise receives order worth USD 2.1 million
Regulatory press release
Bondholders approve amendment to bond terms and conditions
Regulatory press release
ADDvise acquires CliniChain Holding B.V.
Regulatory press release
ADDvise receives order worth USD 1.7 million
Regulatory press release
ADDvise Group successfully places subsequent senior secured bonds of SEK 150 million at par
Regulatory press release
ADDvise Group contemplates issuance of subsequent senior secured bonds
Regulatory press release
ADDvise Group calls for a change of the terms of the company’s senior secured bonds by initiation of a written procedure
Regulatory press release
Interim report January 1 – September 30, 2022
Regulatory press release
ADDvise Group’s nomination committee for the Annual General Meeting 2023
Regulatory press release
ADDvise signs Letter of Intent to acquire CliniChain Holding B.V.
Regulatory press release
ADDvise receives order worth USD 640,000
Regulatory press release
Interim report January 1 – June 30, 2022
Regulatory press release
ADDvise receives allocation decision worth approximately EUR 2.4 million
Regulatory press release
ADDvise receives order from Cadwell Industries worth approximately USD 1.7 million
Regulatory press release
ADDvise acquires Seebreath AB
Regulatory press release
Report from the annual general meeting of ADDvise Group AB (publ) 6th of May 2022
Regulatory press release
Interim report January 1 – March 31 2022
Regulatory press release
ADDvise acquires Surplus Diabetics, Inc.
Regulatory press release
ADDvise Group publishes the annual report 2021
Regulatory press release
ADDvise Group raises its EBITDA target for 2022
Regulatory press release
Notice convening the Annual General Meeting of ADDvise Group AB (publ)
Regulatory press release
ADDvise receives order from SHCS on vital signs monitoring solution worth approximately USD 2 million
Regulatory press release
ADDvise Group completes a directed new share issue of approximately SEK 100 million which was oversubscribed
Regulatory press release
ADDvise Group announces intention to carry out a directed new share issue of approximately SEK 100 million
Regulatory press release
ADDvise receives allocation decision worth approximately SEK 44 million
Regulatory press release
ADDvise acquires JTECH Medical
Regulatory press release
ADDvise signs Letter of Intent to acquire Seebreath AB
Regulatory press release
Year-end report 2021, January 1 – December 31
Regulatory press release
ADDvise acquires Poly Pharmaceuticals, Inc.
Regulatory press release
The nomination committee’s proposal of board of directors in ADDvise Group AB (publ)
Regulatory press release
ADDvise signs Letter of Intent to acquire Surplus Diabetic, Inc.
Regulatory press release
Bondholders approve amendment to bond terms and conditions
Non-regulatory press release
Major shareholder issues call options to board members, senior executives and certain other employees in ADDvise Group
Regulatory press release